Loading
Search products, companies, tests, and guides — go from query to quote request in one place.
Tests
The determination of the ratio of a sub-population of class-switched memory B-lymphocytes to leukocytes present in a sample. The measurement may be expressed as a ratio or percentage.
Tests
A proprietary chemiluminescent microparticle immunoassay (CMIA) used for the qualitative detection of IgG antibodies to SARS-CoV-2 in human serum and plasma on the Abbott Alinity i system. The persistence of immunoglobulin class G (IgG) antibodies may identify people who have been infected in the past, recovered from the illness, and possibly developed immunity.
Tests
A proprietary chemiluminescent microparticle immunoassay (CMIA) used for the qualitative detection of IgG antibodies to SARS-CoV-2 in human serum and plasma on the Abbott ARCHITECT i system. The persistence of immunoglobulin class G (IgG) antibodies may identify people who have been infected in the past, recovered from the illness, and possibly developed immunity.
Tests
The determination of the ratio of antibody-secreting B-lymphocytes to total class-switched memory B-lymphocyte present in a sample. The measurement may be expressed as a ratio or percentage.
Tests
The determination of the amount of antidepressant class drug present in a sample.
Tests
The determination of the amount of barbiturate class agents present in a sample.
Tests
The determination of the amount of cannabinoid class agents present in a sample.
Tests
The determination of the ratio of the class-switched memory B-lymphocytes to total B-lymphocytes present in a sample. The measurement may be expressed as a ratio or percentage.
Tests
The determination of the ratio of class-switched memory B-lymphocytes to leukocytes present in a sample. The measurement may be expressed as a ratio or percentage.
Tests
The determination of the amount of HLA class I antibody present in a sample.
Tests
The determination of the amount of HLA class IA histocompatibility antigen present in a sample.
Tests
The determination of the number of mismatch between the study subject and his or her donor for the human leukocyte antigen, class I, group A (HLA-A).
